Market Overview

TTP plc Completes Expansion of Life Sciences Lab Facility for Desktop Biology Programmes


Dedicated facility developed in response to increasing demand for
product development projects in diagnostics, R&D and bioprocess

TTP plc (TTP), a leading independent technology and product development
company, has completed and moved into a new extension of their life
sciences development facility. The additional multi-disciplinary suite
of lab space provides a Class II bio-handling and tissue culture
laboratory and a dedicated facility for diagnostic system development
under ISO 13485:2016.

The new facilities are part of an ongoing investment at TTP in dedicated
space for system development programmes for life science and diagnostics
companies, and a growing initiative to find biologically derived
solutions for challenges in assay development and biomarker discovery.
TTP has a particular focus on helping customers to develop new products
in molecular and immunodiagnostics, life science R&D and bioprocess,
cell-sorting, bioprinting and microfabrication.

"We have designed these facilities to address the evolving nature of the
programmes we are undertaking," said Piers Harding, Life Science
Engineering Manager at TTP
. "The Class II facility now allows for
TTP teams to undertake assay development and functional tests of systems
with disease-pertinent samples. As our biological team has grown, this
is something our clients have increasingly asked for. The expansion will
work hand in hand with our molecular biology and bioengineering space –
increasingly we are seeing programmes make use of the nearby
micro-fabrication facility we established at TTP last year."

Giles Sanders, of Life Sciences Business Development, said: "This
is part of TTP's ongoing investment in life sciences to provide our
clients with interdisciplinary insight throughout the product
development pathway. Our life sciences team has nearly doubled in size
in the last few years, and this has been augmented by investments in
equipment and robotics as well as internal programmes targeted at
developing new technologies to provide our clients with a competitive
advantage in their future products. This includes not only our Desktop
Biology programmes but also the development of unique cell sorting
technologies and a biomolecule innovation team focusing on solutions for
bacterial concentration and developing constructs for super-stable and
robust antibody analogues."

Piers Harding and Giles Sanders will both be at the 70th AACC Annual
Scientific Meeting & Clinical Lab Expo in Chicago, July 29 - August 2,
2018, where TTP will exhibit the latest advances in TTP Desktop Biology
on stand #1472. This includes further developments of the Puckdx
sample-to-answer diagnostic platform, single-use molecular diagnostic
devices and TTP's fastest and lowest cost PCR thermal control technology
ever – capable of 40 cycles in less than two minutes.

View Comments and Join the Discussion!